N-乙酰半胱氨酸抑制骨髓增殖性肿瘤小鼠模型中的血栓形成
该研究在JAK2V617F敲入的真性红细胞增多症小鼠模型中给予N-乙酰半胱氨酸(NAC)治疗,发现NAC在不影响血常规和脾大的情况下延长小鼠寿命。在急性肺血栓模型中,NAC减少血栓形成的程度与阿司匹林相近,并减少血小板-白细胞聚集体及中性粒细胞胞外诱捕网形成,为NAC降低MPN血栓风险提供临床前依据。
要点
- NAC延长JAK2V617F小鼠寿命,且不影响血常规与脾大
- NAC减少血栓形成的程度与不可逆血小板抑制剂阿司匹林相近
- NAC减少MPN患者及健康对照中性粒细胞胞外诱捕网形成
核心结论
- NAC在JAK2V617F小鼠中抑制血栓形成,为其降低MPN血栓风险提供临床前依据。
研究设计与样本
- 研究采用JAK2V617F敲入的真性红细胞增多症小鼠模型,给予N-乙酰半胱氨酸(NAC)治疗。
- 使用急性肺血栓体内模型评估血栓形成,并进行血小板活化与中性粒细胞胞外诱捕网的体外分析。
主要发现
- NAC治疗延长JAK2V617F小鼠寿命,且未影响血常规或脾大。
- 在急性肺血栓模型中,NAC减少血栓形成的程度与阿司匹林相近。
- NAC减少JAK2V617F小鼠凝血酶诱导的血小板-白细胞聚集体形成。
- NAC减少MPN患者及健康对照原代中性粒细胞的中性粒细胞胞外诱捕网形成。
临床怎么用
- 目前MPN一级预防除阿司匹林和羟基脲等降细胞治疗外选择有限,NAC为值得进一步临床研究的候选抗血栓药物。
局限性
- 结果为小鼠模型及体外实验的临床前证据,尚未在MPN患者中验证疗效与安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thrombosis is a major cause of mortality in patients with myeloproliferative neoplasms (MPNs), though there is currently little to offer patients with MPN beyond aspirin and cytoreductive therapies such as hydroxyurea for primary prevention. Thrombogenesis in MPN involves multiple cellular mechanisms, including platelet activation and neutrophil-extracellular trap formation; therefore, an antithrombotic agent that targets one or more of these processes would be of therapeutic benefit in MPN. Here, we treated the JAK2V617F knockin mouse model of polycythemia vera with N-acetylcysteine (NAC), a sulfhydryl-containing compound with broad effects on glutathione replenishment, free radical scavenging, and reducing disulfide bonds, to investigate its antithrombotic effects in the context of MPN. Strikingly, NAC treatment extended the lifespan of JAK2V617F mice without impacting blood counts or splenomegaly. Using an acute pulmonary thrombosis model in vivo, we found that NAC reduced thrombus formation to a similar extent as the irreversible platelet inhibitor aspirin. In vitro analysis of platelet activation revealed that NAC reduced thrombin-induced platelet-leukocyte aggregate formation in JAK2V617F mice. Furthermore, NAC reduced neutrophil extracellular trap formation in primary human neutrophils from patients with MPN as well as healthy controls. These results provide evidence that N-acetylcysteine inhibits thrombosis in JAK2V617F mice and provide a pre-clinical rationale for investigating NAC as a therapeutic to reduce thrombotic risk in MPN.
引用
- Craver BM, Ramanathan G, Hoang S, et al. N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm. Blood Adv. 2020. PMID: 31978215. doi:10.1182/bloodadvances.2019000967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。